FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Ranbaxy Settles Suit Over Launch of Generic Flomax

[ Price : $8.95]

Ranbaxy Laboratories settles a lawsuit brought by Astellas/Boehringer Ingelheim seeking to block Ranbaxys generic version of Floma...

FDA Draft Guidance on COPD Development

[ Price : $8.95]

A new FDA draft guidance provides the agencys current thinking on developing new molecular entities for treating chronic obstructi...

FDA Clears Bard Endotracheal Tube

[ Price : $8.95]

FDA clears a C. R. Bard 510(k) for the Agento IC silver-coated endotracheal tube.

Orphan Designation for Kiadis Transplant Drug

[ Price : $8.95]

FDA gives orphan drug designation to Kiadis Pharmas lead product as a therapy for immune reconstitution and preventing graft versu...

Presidential Hopeful Edwards Outlines Drug Import Plan

[ Price : $8.95]

Democratic presidential candidate John Edwards outlines his plan to protect Americans from unsafe imported medical products enteri...

Watson Seeks Generic Yaz Approval

[ Price : $8.95]

Watson Pharmaceuticals submits an ANDA for a generic copy of Bayer Scherings contraceptive Yaz.

FDA OKs Norbrooks Labs sANADA for Bovine Parasites

[ Price : $8.95]

Federal Register Final rule: FDA approves a Norbrook Laboratories supplemental ANADA for claims of effectiveness against parasites...

DDMAC Cites Scios Reminder Material for Natrecor

[ Price : $8.95]

DDMAC cites Scios over imagery in drug reminder materials promoting Natrecor.

FDA Withdraws Multiple NDAs, ANDAs

[ Price : $8.95]

Federal Register Notice: FDA withdraws approval of 73 NDAs and 62 ANDAs that are no longer marketed.

FDA OKs Abilify for Adolescent Schizophrenia

[ Price : $8.95]

FDA approves an Otsuka Pharmaceutical supplemental NDA for atypical antipsychotic Abilify (aripiprazole) for treating schizophreni...